Urinary Alpha- and Pi-Glutathione S-Transferases in Adult Patients with Type 1 Diabetes

por von Scholten, Bernt Johan, Theilade, Simone, Lajer, Maria, Rossing, Peter
Publicado 2014

The potential of glucagon-like peptide-1 receptor agonists in heart failure

por Kreiner, Frederik Flindt, Hovingh, G. Kees Kornelis, von Scholten, Bernt Johan
Publicado 2022

Editorial: Advanced Cardiovascular Imaging in Diabetes

por Schick, Fritz, Ripa, Rasmus Sejersten, Hansen, Tine Willum, von Scholten, Bernt Johan
Publicado 2022

Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials

por Kreiner, Frederik Flindt, von Scholten, Bernt Johan, Kurtzhals, Peter, Gough, Stephen Charles Langford
Publicado 2023

Insulin at 100: still central in protein-based therapy for chronic disease

por Kurtzhals, Peter, von Scholten, Bernt Johan, Kreiner, Frederik Flindt, Gough, Stephen Charles Langford
Publicado 2021

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

por von Scholten, Bernt Johan, Kreiner, Frederik Flindt, Rasmussen, Søren, Rossing, Peter, Idorn, Thomas
Publicado 2022

Current and future therapies for type 1 diabetes

por von Scholten, Bernt Johan, Kreiner, Frederik F., Gough, Stephen C. L., von Herrath, Matthias
Publicado 2021

Effect of large weight reductions on measured and estimated kidney function

por von Scholten, Bernt Johan, Persson, Frederik, Svane, Maria S., Hansen, Tine W., Madsbad, Sten, Rossing, Peter
Publicado 2017

Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?

por Christensen, Regitse Højgaard, von Scholten, Bernt Johan, Lehrskov, Louise Lang, Rossing, Peter, Jørgensen, Peter Godsk
Publicado 2020

Obesity-Related Kidney Disease: Current Understanding and Future Perspectives

por Kreiner, Frederik F., Schytz, Philip Andreas, Heerspink, Hiddo J. L., von Scholten, Bernt Johan, Idorn, Thomas
Publicado 2023

Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R(+) T cells

por von Scholten, Bernt Johan, Rosendahl, Alexander, Hasbak, Philip, Bergholdt, Regine, Kjaer, Andreas, Rossing, Peter, Hansen, Tine W.
Publicado 2016

Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

por Christensen, Regitse H., von Scholten, Bernt Johan, Hansen, Christian S., Jensen, Magnus T., Vilsbøll, Tina, Rossing, Peter, Jørgensen, Peter G.
Publicado 2019

The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials

por Zobel, Emilie H., von Scholten, Bernt Johan, Hansen, Tine W., Persson, Frederik, Rasmussen, Søren, Wolthers, Benjamin, Rossing, Peter
Publicado 2021

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial

por Mann, Johannes F. E., Fonseca, Vivian, Mosenzon, Ofri, Raz, Itamar, Goldman, Bryan, Idorn, Thomas, von Scholten, Bernt Johan, Poulter, Neil R.
Publicado 2018

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes – An observational follow-up study

por Frimodt-Møller, Marie, von Scholten, Bernt Johan, Reinhard, Henrik, Jacobsen, Peter Karl, Hansen, Tine Willum, Persson, Frederik Ivar, Parving, Hans-Henrik, Rossing, Peter
Publicado 2018

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and mi...

por Zobel, Emilie H., von Scholten, Bernt Johan, Reinhard, Henrik, Persson, Frederik, Teerlink, Tom, Hansen, Tine W., Parving, Hans-Henrik, Jacobsen, Peter K., Rossing, Peter
Publicado 2017

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with...

por von Scholten, Bernt Johan, Reinhard, Henrik, Hansen, Tine Willum, Lindhardt, Morten, Petersen, Claus Leth, Wiinberg, Niels, Hansen, Peter Riis, Parving, Hans-Henrik, Jacobsen, Peter Karl, Rossing, Peter
Publicado 2015

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

por Persson, Frederik, Bain, Stephen C., Mosenzon, Ofri, Heerspink, Hiddo J.L., Mann, Johannes F.E., Pratley, Richard, Raz, Itamar, Idorn, Thomas, Rasmussen, Søren, von Scholten, Bernt Johan, Rossing, Peter
Publicado 2021

Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial

por Mosenzon, Ofri, Bain, Stephen C., Heerspink, Hiddo J. L., Idorn, Thomas, Mann, Johannes F. E., Persson, Frederik, Pratley, Richard E., Rasmussen, Søren, Rossing, Peter, von Scholten, Bernt Johan, Raz, Itamar
Publicado 2020

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria

por Currie, Gemma E., von Scholten, Bernt Johan, Mary, Sheon, Flores Guerrero, Jose-Luis, Lindhardt, Morten, Reinhard, Henrik, Jacobsen, Peter K., Mullen, William, Parving, Hans-Henrik, Mischak, Harald, Rossing, Peter, Delles, Christian
Publicado 2018